Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

15 treatments under study, led by Chewing Gum

Research Leaders

7 sponsors active, led by Bursa Yuksek Ihtisas Training and Research Hospital

Related Conditions

Often studied with 12 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 6 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (6)

Trial Status

Completed5
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (6)

Research Network

Common Treatments

  • Chewing Gum2
  • Degree Of Nausea1
  • Chewing Gum Group Group 21
  • Surgeon Satisfaction1
  • Wrigley Extra White Soft Chew Peppermint Chewing Gum1

Active Sponsors

  • Bursa Yuksek Ihtisas Training and Research Hospital1
  • Seoul National University Hospital1
  • Hacettepe University1
  • Istanbul Demiroglu Bilim University1
  • King Abdullah University Hospital1

Top Investigators

Related Conditions

  • Asthma Bronchiale1
  • Breast Cancer1
  • Mouthwashes1
  • Feno1
  • Dental Plaque1

Activity Timeline